Rallybio(RLYB)
NEW HAVEN, CT
BiotechnologyFocus: Therapeutics
Rallybio is a life sciences company focused on Therapeutics.
Oncology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Clinical data collection
Fetal and Neonatal Alloimmune ThrombocytopeniaClinical Trials (1)
NCT05345561Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia
N/ARLYB116 for Injection
Hematologic DiseasesClinical Trials (1)
NCT06797375Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy Participants
Phase 1Phase 2
Clinical Trials (1)
NCT06435845Phase 2 Study on the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a Alloimmunization
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 3 clinical trials
Top TAs: Hematology, Immunology
Publications: 11 in PubMed
SEC Filings: 2 available
Financials (FY2024)
Revenue
$600K
R&D Spend
$54M(8924%)32%
Net Income
-$75MCash
$24MHiring Trend
Stable
0
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles